| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 5.86e-09 | 11 | 135 | 5 | GO:0098973 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 1.22e-08 | 42 | 135 | 7 | GO:0098918 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.39e-06 | 118 | 135 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 2.28e-06 | 32 | 135 | 5 | GO:0099186 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 2.88e-06 | 130 | 135 | 8 | GO:0005200 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 1.23e-04 | 38 | 135 | 4 | GO:0000146 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 2.70e-04 | 4 | 135 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | carnitine O-palmitoyltransferase activity | 2.70e-04 | 4 | 135 | 2 | GO:0004095 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH4 DNAH3 MYO7B ABCA12 KIF26B ACTC1 RNF213 ATP13A2 KIF9 MLH3 DNAH12 ATP1A4 TNNT2 | 2.74e-04 | 614 | 135 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase activity | 2.94e-04 | 86 | 135 | 5 | GO:0004197 | |
| GeneOntologyMolecularFunction | glucosyltransferase activity | 4.24e-04 | 22 | 135 | 3 | GO:0046527 | |
| GeneOntologyMolecularFunction | kininogen binding | 4.48e-04 | 5 | 135 | 2 | GO:0030984 | |
| GeneOntologyMolecularFunction | O-palmitoyltransferase activity | 4.48e-04 | 5 | 135 | 2 | GO:0016416 | |
| GeneOntologyMolecularFunction | carnitine O-acyltransferase activity | 6.69e-04 | 6 | 135 | 2 | GO:0016406 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 6.69e-04 | 6 | 135 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | exopeptidase activity | 9.10e-04 | 110 | 135 | 5 | GO:0008238 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 9.66e-04 | 167 | 135 | 6 | GO:0015079 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 1.18e-03 | 31 | 135 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | structural constituent of presynaptic active zone | 1.24e-03 | 8 | 135 | 2 | GO:0098882 | |
| GeneOntologyMolecularFunction | metalloexopeptidase activity | 1.30e-03 | 70 | 135 | 4 | GO:0008235 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.30e-03 | 70 | 135 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 1.42e-03 | 33 | 135 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | lncRNA binding | 1.69e-03 | 35 | 135 | 3 | GO:0106222 | |
| GeneOntologyBiologicalProcess | mesenchyme migration | 9.00e-09 | 5 | 136 | 4 | GO:0090131 | |
| GeneOntologyBiologicalProcess | postsynaptic actin cytoskeleton organization | 1.71e-06 | 31 | 136 | 5 | GO:0098974 | |
| GeneOntologyBiologicalProcess | modified amino acid metabolic process | 1.89e-06 | 218 | 136 | 10 | GO:0006575 | |
| GeneOntologyBiologicalProcess | actin filament-based process | MYH4 WASHC4 HCN4 EPB41L4B MYO7B POTEF ACTBL2 PECAM1 ACTA1 ACTA2 ACTC1 BBS4 POTEKP POF1B RYR2 PGM5 POTEE MTOR POTEI TNNT2 | 2.28e-06 | 912 | 136 | 20 | GO:0030029 |
| GeneOntologyBiologicalProcess | postsynaptic cytoskeleton organization | 3.21e-06 | 35 | 136 | 5 | GO:0099188 | |
| GeneOntologyBiologicalProcess | mesenchyme morphogenesis | 6.96e-05 | 65 | 136 | 5 | GO:0072132 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 7.07e-05 | 153 | 136 | 7 | GO:0030048 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | WASHC4 EPB41L4B MYO7B POTEF ACTBL2 PECAM1 ACTA1 ACTC1 BBS4 POTEKP POF1B PGM5 POTEE MTOR POTEI TNNT2 | 8.02e-05 | 803 | 136 | 16 | GO:0030036 |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH4 AMPH MYO7B POTEF ACTBL2 ACTA1 ACTA2 TOPBP1 ACTC1 ACTG2 POTEKP POF1B PGM5 POTEE KIF9 POTEI TNNT2 | 2.13e-07 | 576 | 136 | 17 | GO:0015629 |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 1.89e-06 | 32 | 136 | 5 | GO:0035267 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 1.89e-06 | 32 | 136 | 5 | GO:0043189 | |
| GeneOntologyCellularComponent | actin filament | 5.18e-06 | 146 | 136 | 8 | GO:0005884 | |
| GeneOntologyCellularComponent | supramolecular fiber | MYH4 DNAH3 KIF26B POTEF ACTBL2 PECAM1 ACTA1 ACTA2 ACTC1 ACTG2 POTEKP GRIN2B KRT79 POF1B RYR1 RYR2 PGM5 POTEE KIF9 DNAH12 POTEI TNNT2 | 7.44e-06 | 1179 | 136 | 22 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | MYH4 DNAH3 KIF26B POTEF ACTBL2 PECAM1 ACTA1 ACTA2 ACTC1 ACTG2 POTEKP GRIN2B KRT79 POF1B RYR1 RYR2 PGM5 POTEE KIF9 DNAH12 POTEI TNNT2 | 8.27e-06 | 1187 | 136 | 22 | GO:0099081 |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 1.07e-05 | 45 | 136 | 5 | GO:1902562 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 2.07e-05 | 290 | 136 | 10 | GO:0043292 | |
| GeneOntologyCellularComponent | photoreceptor ribbon synapse | 2.05e-04 | 18 | 136 | 3 | GO:0098684 | |
| GeneOntologyCellularComponent | sarcomere | 2.30e-04 | 249 | 136 | 8 | GO:0030017 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 3.74e-04 | 94 | 136 | 5 | GO:0000123 | |
| GeneOntologyCellularComponent | smooth muscle contractile fiber | 4.15e-04 | 5 | 136 | 2 | GO:0030485 | |
| GeneOntologyCellularComponent | myofibril | 4.26e-04 | 273 | 136 | 8 | GO:0030016 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 5.95e-04 | 104 | 136 | 5 | GO:0031248 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 7.36e-04 | 109 | 136 | 5 | GO:1902493 | |
| GeneOntologyCellularComponent | mitotic cohesin complex | 8.64e-04 | 7 | 136 | 2 | GO:0030892 | |
| GeneOntologyCellularComponent | ribbon synapse | 1.16e-03 | 32 | 136 | 3 | GO:0097470 | |
| GeneOntologyCellularComponent | filopodium | 1.27e-03 | 123 | 136 | 5 | GO:0030175 | |
| GeneOntologyCellularComponent | inner dynein arm | 1.83e-03 | 10 | 136 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | junctional sarcoplasmic reticulum membrane | 1.83e-03 | 10 | 136 | 2 | GO:0014701 | |
| GeneOntologyCellularComponent | cohesin complex | 2.22e-03 | 11 | 136 | 2 | GO:0008278 | |
| GeneOntologyCellularComponent | motile cilium | 2.29e-03 | 355 | 136 | 8 | GO:0031514 | |
| GeneOntologyCellularComponent | actin-based cell projection | 2.32e-03 | 278 | 136 | 7 | GO:0098858 | |
| GeneOntologyCellularComponent | blood microparticle | 2.53e-03 | 144 | 136 | 5 | GO:0072562 | |
| MousePheno | absent intersomitic vessels | 9.84e-06 | 6 | 112 | 3 | MP:0012254 | |
| Domain | Actin_CS | 6.56e-14 | 16 | 133 | 8 | IPR004001 | |
| Domain | ACTINS_2 | 1.23e-13 | 17 | 133 | 8 | PS00432 | |
| Domain | Actin/actin-like_CS | 2.20e-13 | 18 | 133 | 8 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 3.78e-13 | 19 | 133 | 8 | PS01132 | |
| Domain | Actin | 3.67e-11 | 31 | 133 | 8 | IPR004000 | |
| Domain | Actin | 3.67e-11 | 31 | 133 | 8 | PF00022 | |
| Domain | ACTIN | 3.67e-11 | 31 | 133 | 8 | SM00268 | |
| Domain | ACTINS_1 | 9.35e-10 | 8 | 133 | 5 | PS00406 | |
| Domain | Ryanodine_rcpt | 1.50e-04 | 3 | 133 | 2 | IPR003032 | |
| Domain | Ryanrecept_TM4-6 | 1.50e-04 | 3 | 133 | 2 | IPR009460 | |
| Domain | RyR | 1.50e-04 | 3 | 133 | 2 | PF02026 | |
| Domain | RR_TM4-6 | 1.50e-04 | 3 | 133 | 2 | PF06459 | |
| Domain | Ryan_recept | 1.50e-04 | 3 | 133 | 2 | IPR013333 | |
| Domain | SANT/Myb | 5.11e-04 | 52 | 133 | 4 | IPR001005 | |
| Domain | RIH_assoc-dom | 7.41e-04 | 6 | 133 | 2 | IPR013662 | |
| Domain | Ins145_P3_rec | 7.41e-04 | 6 | 133 | 2 | PF08709 | |
| Domain | RIH_assoc | 7.41e-04 | 6 | 133 | 2 | PF08454 | |
| Domain | RIH_dom | 7.41e-04 | 6 | 133 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 7.41e-04 | 6 | 133 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 7.41e-04 | 6 | 133 | 2 | IPR015925 | |
| Domain | - | 7.41e-04 | 6 | 133 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 7.41e-04 | 6 | 133 | 2 | PF01365 | |
| Domain | THIOL_PROTEASE_CYS | 8.14e-04 | 26 | 133 | 3 | PS00139 | |
| Domain | THIOL_PROTEASE_ASN | 9.11e-04 | 27 | 133 | 3 | PS00640 | |
| Domain | THIOL_PROTEASE_HIS | 9.11e-04 | 27 | 133 | 3 | PS00639 | |
| Domain | Pept_cys_AS | 1.02e-03 | 28 | 133 | 3 | IPR000169 | |
| Domain | Carn_acyl_trans | 1.03e-03 | 7 | 133 | 2 | IPR000542 | |
| Domain | Carn_acyltransf | 1.03e-03 | 7 | 133 | 2 | PF00755 | |
| Domain | ACYLTRANSF_C_1 | 1.03e-03 | 7 | 133 | 2 | PS00439 | |
| Domain | ACYLTRANSF_C_2 | 1.03e-03 | 7 | 133 | 2 | PS00440 | |
| Domain | Ion_trans_dom | 1.34e-03 | 114 | 133 | 5 | IPR005821 | |
| Domain | Ion_trans | 1.34e-03 | 114 | 133 | 5 | PF00520 | |
| Domain | Pept_asp_AS | 2.18e-03 | 10 | 133 | 2 | IPR025661 | |
| Domain | MIR | 2.18e-03 | 10 | 133 | 2 | PF02815 | |
| Domain | MIR_motif | 2.18e-03 | 10 | 133 | 2 | IPR016093 | |
| Domain | MIR | 2.18e-03 | 10 | 133 | 2 | PS50919 | |
| Domain | MIR | 2.18e-03 | 10 | 133 | 2 | SM00472 | |
| Domain | Pept_his_AS | 2.65e-03 | 11 | 133 | 2 | IPR025660 | |
| Domain | - | 2.65e-03 | 11 | 133 | 2 | 3.40.50.1220 | |
| Domain | Peptidase_M28 | 3.17e-03 | 12 | 133 | 2 | PF04389 | |
| Domain | DHS-like_NAD/FAD-binding_dom | 3.17e-03 | 12 | 133 | 2 | IPR029035 | |
| Domain | Peptidase_M28 | 3.17e-03 | 12 | 133 | 2 | IPR007484 | |
| Domain | ELM2_dom | 3.73e-03 | 13 | 133 | 2 | IPR000949 | |
| Domain | Pept_C1 | 3.73e-03 | 13 | 133 | 2 | SM00645 | |
| Domain | Peptidase_C1A_C | 3.73e-03 | 13 | 133 | 2 | IPR000668 | |
| Domain | Peptidase_C1 | 3.73e-03 | 13 | 133 | 2 | PF00112 | |
| Domain | ELM2 | 3.73e-03 | 13 | 133 | 2 | PF01448 | |
| Domain | ELM2 | 3.73e-03 | 13 | 133 | 2 | PS51156 | |
| Domain | ELM2 | 3.73e-03 | 13 | 133 | 2 | SM01189 | |
| Domain | Peptidase_C1A | 3.73e-03 | 13 | 133 | 2 | IPR013128 | |
| Domain | Dynein_heavy_chain_D4_dom | 4.33e-03 | 14 | 133 | 2 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 4.33e-03 | 14 | 133 | 2 | IPR013602 | |
| Domain | DHC_N2 | 4.33e-03 | 14 | 133 | 2 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 4.33e-03 | 14 | 133 | 2 | IPR011704 | |
| Domain | K_chnl_volt-dep_EAG/ELK/ERG | 4.33e-03 | 14 | 133 | 2 | IPR003938 | |
| Domain | AAA_8 | 4.33e-03 | 14 | 133 | 2 | PF12780 | |
| Domain | AAA_5 | 4.33e-03 | 14 | 133 | 2 | PF07728 | |
| Domain | - | 4.83e-03 | 48 | 133 | 3 | 2.60.120.10 | |
| Domain | DHC_fam | 4.97e-03 | 15 | 133 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 4.97e-03 | 15 | 133 | 2 | PF03028 | |
| Domain | PI3/4_kinase_CS | 4.97e-03 | 15 | 133 | 2 | IPR018936 | |
| Domain | Dynein_heavy_dom | 4.97e-03 | 15 | 133 | 2 | IPR004273 | |
| Domain | SANT | 5.42e-03 | 50 | 133 | 3 | SM00717 | |
| Domain | - | 5.66e-03 | 16 | 133 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 5.66e-03 | 16 | 133 | 2 | SM00146 | |
| Domain | RmlC-like_jellyroll | 5.73e-03 | 51 | 133 | 3 | IPR014710 | |
| Domain | TPR-like_helical_dom | 6.51e-03 | 233 | 133 | 6 | IPR011990 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 3.88e-05 | 165 | 108 | 8 | MM15026 | |
| Pathway | REACTOME_SULFUR_AMINO_ACID_METABOLISM | 5.79e-05 | 28 | 108 | 4 | M547 | |
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 1.56e-11 | 15 | 136 | 6 | 16824795 | |
| Pubmed | 3.85e-10 | 11 | 136 | 5 | 30962377 | ||
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | RPL36 POTEF ACTBL2 ACTA1 ACTA2 ACTC1 POTEKP KRT79 DPM1 POTEE POTEI TARS1 | 1.68e-09 | 288 | 136 | 12 | 31501420 |
| Pubmed | Virus assembly and plasma membrane domains: which came first? | 3.33e-09 | 6 | 136 | 4 | 22989508 | |
| Pubmed | 3.33e-09 | 6 | 136 | 4 | 12009869 | ||
| Pubmed | HIV-1 Tat protein variants: critical role for the cysteine region in synaptodendritic injury. | 3.33e-09 | 6 | 136 | 4 | 23811015 | |
| Pubmed | Retroviral assembly and budding occur through an actin-driven mechanism. | 3.33e-09 | 6 | 136 | 4 | 19883584 | |
| Pubmed | Dynamic imaging of cell-free and cell-associated viral capture in mature dendritic cells. | 3.33e-09 | 6 | 136 | 4 | 21917091 | |
| Pubmed | HIV-1 Gag protein associates with F-actin present in microfilaments. | 3.33e-09 | 6 | 136 | 4 | 8661406 | |
| Pubmed | 3.33e-09 | 6 | 136 | 4 | 23017337 | ||
| Pubmed | 3.33e-09 | 6 | 136 | 4 | 9841925 | ||
| Pubmed | Actin associates with the nucleocapsid domain of the human immunodeficiency virus Gag polyprotein. | 3.33e-09 | 6 | 136 | 4 | 9971772 | |
| Pubmed | Interaction of the human immunodeficiency virus type 1 nucleocapsid with actin. | 3.33e-09 | 6 | 136 | 4 | 10074138 | |
| Pubmed | HIV-1 protease cleaves actin during acute infection of human T-lymphocytes. | 3.33e-09 | 6 | 136 | 4 | 1540415 | |
| Pubmed | HIV type 1 Gag and nucleocapsid proteins: cytoskeletal localization and effects on cell motility. | 3.33e-09 | 6 | 136 | 4 | 11709093 | |
| Pubmed | 3.33e-09 | 6 | 136 | 4 | 10049817 | ||
| Pubmed | Synaptodendritic recovery following HIV Tat exposure: neurorestoration by phytoestrogens. | 3.33e-09 | 6 | 136 | 4 | 23875777 | |
| Pubmed | 7.76e-09 | 7 | 136 | 4 | 22535526 | ||
| Pubmed | HIV-1 replication from after cell entry to the nuclear periphery. | 7.76e-09 | 7 | 136 | 4 | 17504171 | |
| Pubmed | Selective targeting of ITK blocks multiple steps of HIV replication. | 7.76e-09 | 7 | 136 | 4 | 18443296 | |
| Pubmed | The trinity of the cortical actin in the initiation of HIV-1 infection. | 7.76e-09 | 7 | 136 | 4 | 22640593 | |
| Pubmed | 7.76e-09 | 7 | 136 | 4 | 22465675 | ||
| Pubmed | Mice lacking factor VII develop normally but suffer fatal perinatal bleeding. | 7.76e-09 | 7 | 136 | 4 | 9384381 | |
| Pubmed | 1.55e-08 | 8 | 136 | 4 | 20147394 | ||
| Pubmed | 1.55e-08 | 8 | 136 | 4 | 23260110 | ||
| Pubmed | 1.55e-08 | 8 | 136 | 4 | 14694110 | ||
| Pubmed | KCNH7 ABCA12 POTEF ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 POTEKP PGD POTEE ADAMTS6 UGT8 OSMR | 1.59e-08 | 513 | 136 | 14 | 25798074 | |
| Pubmed | Myocardial Mycn is essential for mouse ventricular wall morphogenesis. | 1.64e-08 | 21 | 136 | 5 | 23063798 | |
| Pubmed | Functional interaction between the cytoplasmic leucine-zipper domain of HIV-1 gp41 and p115-RhoGEF. | 2.78e-08 | 9 | 136 | 4 | 10556093 | |
| Pubmed | Cytoskeletal proteins inside human immunodeficiency virus type 1 virions. | 2.78e-08 | 9 | 136 | 4 | 8892894 | |
| Pubmed | 2.78e-08 | 9 | 136 | 4 | 18775311 | ||
| Pubmed | 4.61e-08 | 10 | 136 | 4 | 1907279 | ||
| Pubmed | Non-viral cellular substrates for human immunodeficiency virus type 1 protease. | 4.61e-08 | 10 | 136 | 4 | 1991513 | |
| Pubmed | 4.61e-08 | 10 | 136 | 4 | 23575248 | ||
| Pubmed | Reexamination of chromosomal loci of human muscle actin genes by fluorescence in situ hybridization. | 5.85e-08 | 3 | 136 | 3 | 7780165 | |
| Pubmed | N-terminal Slit2 inhibits HIV-1 replication by regulating the actin cytoskeleton. | 7.23e-08 | 11 | 136 | 4 | 23294842 | |
| Pubmed | 7.23e-08 | 11 | 136 | 4 | 34368133 | ||
| Pubmed | Quantitative proteomic analysis of lentiviral vectors using 2-DE. | 7.23e-08 | 11 | 136 | 4 | 19639585 | |
| Pubmed | Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms. | ERBB3 POTEF ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 POTEKP POTEE PTCD3 | 7.39e-08 | 256 | 136 | 10 | 24189400 |
| Pubmed | 1.07e-07 | 96 | 136 | 7 | 23580065 | ||
| Pubmed | 1.08e-07 | 12 | 136 | 4 | 23071112 | ||
| Pubmed | 1.08e-07 | 12 | 136 | 4 | 22312437 | ||
| Pubmed | NRSF regulates the fetal cardiac gene program and maintains normal cardiac structure and function. | 1.08e-07 | 12 | 136 | 4 | 14633990 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | POTEF ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 POTEKP POTEE POTEI ATP1A4 | 1.26e-07 | 271 | 136 | 10 | 32433965 |
| Pubmed | Loss of both GATA4 and GATA6 blocks cardiac myocyte differentiation and results in acardia in mice. | 1.56e-07 | 13 | 136 | 4 | 18400219 | |
| Pubmed | 1.82e-07 | 214 | 136 | 9 | 22199357 | ||
| Pubmed | 2.17e-07 | 14 | 136 | 4 | 21923909 | ||
| Pubmed | 2.17e-07 | 14 | 136 | 4 | 17411366 | ||
| Pubmed | In vitro generation of functional murine heart organoids via FGF4 and extracellular matrix. | 2.95e-07 | 15 | 136 | 4 | 32883967 | |
| Pubmed | 5.12e-07 | 17 | 136 | 4 | 17360745 | ||
| Pubmed | 5.12e-07 | 17 | 136 | 4 | 8997639 | ||
| Pubmed | Meteorin regulates angiogenesis at the gliovascular interface. | 5.82e-07 | 5 | 136 | 3 | 18059000 | |
| Pubmed | 5.82e-07 | 5 | 136 | 3 | 31180722 | ||
| Pubmed | LncCMRR Plays an Important Role in Cardiac Differentiation by Regulating the Purb/Flk1 Axis. | 6.56e-07 | 18 | 136 | 4 | 36318802 | |
| Pubmed | 6.56e-07 | 18 | 136 | 4 | 24840128 | ||
| Pubmed | 8.28e-07 | 19 | 136 | 4 | 18725519 | ||
| Pubmed | Heart-specific ablation of Prkar1a causes failure of heart development and myxomagenesis. | 8.28e-07 | 19 | 136 | 4 | 18316483 | |
| Pubmed | PBX transcription factors drive pulmonary vascular adaptation to birth. | 8.28e-07 | 19 | 136 | 4 | 29251627 | |
| Pubmed | 1.16e-06 | 6 | 136 | 3 | 34646377 | ||
| Pubmed | EZH2 controls epicardial cell migration during heart development. | 1.16e-06 | 6 | 136 | 3 | 37037595 | |
| Pubmed | 1.16e-06 | 6 | 136 | 3 | 17656671 | ||
| Pubmed | Resident c-kit(+) cells in the heart are not cardiac stem cells. | 1.16e-06 | 6 | 136 | 3 | 26515110 | |
| Pubmed | Tbx1 regulates proliferation and differentiation of multipotent heart progenitors. | 1.16e-06 | 6 | 136 | 3 | 19745164 | |
| Pubmed | 1.16e-06 | 6 | 136 | 3 | 16881058 | ||
| Pubmed | Modifications in the human T cell proteome induced by intracellular HIV-1 Tat protein expression. | 1.55e-06 | 22 | 136 | 4 | 16526095 | |
| Pubmed | Essential and supporting host cell factors for HIV-1 budding. | 1.87e-06 | 23 | 136 | 4 | 22004035 | |
| Pubmed | 1.93e-06 | 147 | 136 | 7 | 26465331 | ||
| Pubmed | Adam10 is essential for early embryonic cardiovascular development. | 2.02e-06 | 7 | 136 | 3 | 20803506 | |
| Pubmed | 2.02e-06 | 7 | 136 | 3 | 25681586 | ||
| Pubmed | LPA4 regulates blood and lymphatic vessel formation during mouse embryogenesis. | 2.02e-06 | 7 | 136 | 3 | 20713964 | |
| Pubmed | 2.02e-06 | 7 | 136 | 3 | 17258700 | ||
| Pubmed | 2.02e-06 | 7 | 136 | 3 | 34079011 | ||
| Pubmed | HCN4 dynamically marks the first heart field and conduction system precursors. | 2.02e-06 | 7 | 136 | 3 | 23743334 | |
| Pubmed | 2.02e-06 | 7 | 136 | 3 | 30289203 | ||
| Pubmed | Sall1 transiently marks undifferentiated heart precursors and regulates their fate. | 2.02e-06 | 7 | 136 | 3 | 26876450 | |
| Pubmed | ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. | 3.02e-06 | 57 | 136 | 5 | 23788249 | |
| Pubmed | 3.13e-06 | 26 | 136 | 4 | 24742657 | ||
| Pubmed | Loss of endothelial Tie1 receptor impairs lymphatic vessel development-brief report. | 3.23e-06 | 8 | 136 | 3 | 19910638 | |
| Pubmed | Epicardial cell lineages and the origin of the coronary endothelium. | 3.23e-06 | 8 | 136 | 3 | 32068311 | |
| Pubmed | The ShcA phosphotyrosine docking protein sensitizes cardiovascular signaling in the mouse embryo. | 3.23e-06 | 8 | 136 | 3 | 10809671 | |
| Pubmed | 3.23e-06 | 8 | 136 | 3 | 16546160 | ||
| Pubmed | 3.23e-06 | 8 | 136 | 3 | 18245384 | ||
| Pubmed | 3.23e-06 | 8 | 136 | 3 | 2983233 | ||
| Pubmed | 3.23e-06 | 8 | 136 | 3 | 17438136 | ||
| Pubmed | Cathepsin proteases have distinct roles in trophoblast function and vascular remodelling. | 3.23e-06 | 8 | 136 | 3 | 18776147 | |
| Pubmed | Urothelial sonic hedgehog signaling plays an important role in bladder smooth muscle formation. | 3.23e-06 | 8 | 136 | 3 | 17490411 | |
| Pubmed | 3.23e-06 | 8 | 136 | 3 | 38755146 | ||
| Pubmed | 3.23e-06 | 8 | 136 | 3 | 34694145 | ||
| Pubmed | 3.23e-06 | 8 | 136 | 3 | 19705428 | ||
| Pubmed | 3.23e-06 | 8 | 136 | 3 | 20096780 | ||
| Pubmed | Nkx2-5 suppresses the proliferation of atrial myocytes and conduction system. | 3.23e-06 | 8 | 136 | 3 | 24563458 | |
| Pubmed | Reassessment of Isl1 and Nkx2-5 cardiac fate maps using a Gata4-based reporter of Cre activity. | 3.23e-06 | 8 | 136 | 3 | 18775691 | |
| Pubmed | 3.36e-06 | 304 | 136 | 9 | 32235678 | ||
| Pubmed | Notch signaling is essential for ventricular chamber development. | 3.66e-06 | 27 | 136 | 4 | 17336907 | |
| Pubmed | 3.66e-06 | 27 | 136 | 4 | 25631042 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | EPHX2 AOC1 MAN2B2 POTEF ACTA1 ACTA2 ACTC1 ACTG2 POTEKP KRT79 PGD POTEE FOLH1B POTEI CTSB CDH11 | 4.77e-06 | 1070 | 136 | 16 | 23533145 |
| Pubmed | 4.83e-06 | 9 | 136 | 3 | 9827803 | ||
| Pubmed | 4.83e-06 | 9 | 136 | 3 | 29202929 | ||
| Pubmed | 4.83e-06 | 9 | 136 | 3 | 29920846 | ||
| Pubmed | 4.83e-06 | 9 | 136 | 3 | 11807029 | ||
| Interaction | ACTG2 interactions | 3.63e-11 | 49 | 136 | 9 | int:ACTG2 | |
| Interaction | ERRFI1 interactions | PPM1D POTEF ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 POTEKP POTEE GTF2H2 | 2.83e-09 | 107 | 136 | 10 | int:ERRFI1 |
| Interaction | GC interactions | 8.70e-09 | 62 | 136 | 8 | int:GC | |
| Interaction | CAP2 interactions | 1.44e-08 | 66 | 136 | 8 | int:CAP2 | |
| Interaction | POTEJ interactions | 5.67e-08 | 52 | 136 | 7 | int:POTEJ | |
| Interaction | ACTA2 interactions | ERBB3 POTEF ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 POTEKP POF1B POTEE OR1A1 POTEI TNNT2 SMURF2 | 1.31e-07 | 355 | 136 | 14 | int:ACTA2 |
| Interaction | POTEE interactions | 3.18e-07 | 134 | 136 | 9 | int:POTEE | |
| Interaction | ANGPTL8 interactions | 4.04e-07 | 10 | 136 | 4 | int:ANGPTL8 | |
| Interaction | WASH8P interactions | 6.31e-07 | 11 | 136 | 4 | int:WASH8P | |
| Interaction | NAA80 interactions | 2.56e-06 | 15 | 136 | 4 | int:NAA80 | |
| Interaction | SCIN interactions | 2.57e-06 | 58 | 136 | 6 | int:SCIN | |
| Interaction | ABRA interactions | 4.14e-06 | 36 | 136 | 5 | int:ABRA | |
| Interaction | LRRC20 interactions | 7.11e-06 | 19 | 136 | 4 | int:LRRC20 | |
| Interaction | POTEI interactions | 7.17e-06 | 105 | 136 | 7 | int:POTEI | |
| Interaction | NEK4 interactions | KCNH7 ABCA12 POTEF ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 POTEKP PGD POTEE ADAMTS6 MTR UGT8 OSMR | 9.36e-06 | 582 | 136 | 15 | int:NEK4 |
| Interaction | CAP1 interactions | 1.16e-05 | 207 | 136 | 9 | int:CAP1 | |
| Interaction | TSPAN14 interactions | 1.64e-05 | 8 | 136 | 3 | int:TSPAN14 | |
| Interaction | RNF217 interactions | 2.45e-05 | 9 | 136 | 3 | int:RNF217 | |
| Interaction | NDUFA4L2 interactions | 3.09e-05 | 27 | 136 | 4 | int:NDUFA4L2 | |
| Interaction | PFN3 interactions | 3.48e-05 | 10 | 136 | 3 | int:PFN3 | |
| Interaction | TFCP2 interactions | RPL36 POTEF ACTBL2 ACTA1 ACTA2 ACTC1 POTEKP KRT79 DPM1 POTEE POTEI TARS1 | 4.08e-05 | 436 | 136 | 12 | int:TFCP2 |
| Interaction | PHACTR2 interactions | 4.13e-05 | 29 | 136 | 4 | int:PHACTR2 | |
| Interaction | AFM interactions | 4.77e-05 | 11 | 136 | 3 | int:AFM | |
| Interaction | ACTG1 interactions | ERBB3 KIF26B POTEF ACTBL2 ACTA1 ACTA2 TOPBP1 ACTC1 ACTG2 EZH2 POTEE CTBP2 POTEI | 5.20e-05 | 520 | 136 | 13 | int:ACTG1 |
| Interaction | C9orf43 interactions | 6.33e-05 | 12 | 136 | 3 | int:C9orf43 | |
| Interaction | ABTB2 interactions | 6.34e-05 | 101 | 136 | 6 | int:ABTB2 | |
| Interaction | LCN6 interactions | 8.97e-05 | 67 | 136 | 5 | int:LCN6 | |
| Interaction | PROK2 interactions | 1.04e-04 | 14 | 136 | 3 | int:PROK2 | |
| Interaction | RNASE3 interactions | 1.04e-04 | 14 | 136 | 3 | int:RNASE3 | |
| Interaction | FBXO40 interactions | 1.29e-04 | 15 | 136 | 3 | int:FBXO40 | |
| Interaction | OR1A1 interactions | 1.35e-04 | 3 | 136 | 2 | int:OR1A1 | |
| Interaction | ACADS interactions | 1.50e-04 | 40 | 136 | 4 | int:ACADS | |
| Interaction | ERBB3 interactions | ERBB3 POTEF ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 POTEKP POTEE PTCD3 | 1.51e-04 | 355 | 136 | 10 | int:ERBB3 |
| Interaction | MNAT1 interactions | 1.57e-04 | 119 | 136 | 6 | int:MNAT1 | |
| Interaction | POTEF interactions | 1.61e-04 | 228 | 136 | 8 | int:POTEF | |
| Interaction | VAV1 interactions | 1.61e-04 | 228 | 136 | 8 | int:VAV1 | |
| Interaction | ACTN2 interactions | 1.63e-04 | 171 | 136 | 7 | int:ACTN2 | |
| Interaction | ACTBL2 interactions | 1.85e-04 | 296 | 136 | 9 | int:ACTBL2 | |
| Interaction | REG3A interactions | 1.91e-04 | 17 | 136 | 3 | int:REG3A | |
| Interaction | TMSB4X interactions | 2.08e-04 | 80 | 136 | 5 | int:TMSB4X | |
| Interaction | TMOD3 interactions | 2.49e-04 | 243 | 136 | 8 | int:TMOD3 | |
| Cytoband | 2q21.1 | 8.56e-07 | 58 | 136 | 5 | 2q21.1 | |
| Cytoband | 1q32 | 4.24e-04 | 49 | 136 | 3 | 1q32 | |
| GeneFamily | Actins | 1.36e-08 | 6 | 101 | 4 | 929 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 6.31e-07 | 13 | 101 | 4 | 685 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 9.24e-05 | 3 | 101 | 2 | 287 | |
| Coexpression | KUNINGER_IGF1_VS_PDGFB_TARGETS_UP | 4.43e-06 | 82 | 136 | 6 | M9065 | |
| Coexpression | KUNINGER_IGF1_VS_PDGFB_TARGETS_UP | 4.43e-06 | 82 | 136 | 6 | MM1188 | |
| Coexpression | GSE15750_DAY6_VS_DAY10_EFF_CD8_TCELL_DN | 1.02e-05 | 200 | 136 | 8 | M3579 | |
| Coexpression | HORIUCHI_WTAP_TARGETS_UP | 3.54e-05 | 309 | 136 | 9 | M1973 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | USP34 AMPH WASHC4 STAG1 TOPBP1 MAST2 ADAM10 STK10 RCOR1 PIK3C3 MTR CTBP2 OSMR PLOD2 SMURF2 | 3.99e-05 | 856 | 136 | 15 | M4500 |
| Coexpression | PARENT_MTOR_SIGNALING_UP | USP34 PECAM1 BBS4 CPT2 MAST2 MTOR HPS4 PCIF1 TXNRD3 CTBP2 CTH BRWD1 | 4.16e-05 | 567 | 136 | 12 | M16909 |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER | 6.05e-05 | 41 | 136 | 4 | M47988 | |
| Coexpression | GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP | 8.36e-05 | 199 | 136 | 7 | M7021 | |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_16H_DN | 8.36e-05 | 199 | 136 | 7 | M8259 | |
| Coexpression | GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TGFB_TREATED_CD4_TCELL_UP | 8.36e-05 | 199 | 136 | 7 | M7852 | |
| Coexpression | GSE22443_NAIVE_VS_ACT_AND_IL12_TREATED_CD8_TCELL_UP | 8.63e-05 | 200 | 136 | 7 | M8221 | |
| Coexpression | GSE37301_MULTIPOTENT_PROGENITOR_VS_COMMON_LYMPHOID_PROGENITOR_DN | 8.63e-05 | 200 | 136 | 7 | M8842 | |
| Coexpression | LE_SKI_TARGETS_UP | 8.81e-05 | 17 | 136 | 3 | M362 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#4_top-relative-expression-ranked_500 | 4.66e-07 | 48 | 130 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#4_top-relative-expression-ranked_100 | 4.72e-07 | 26 | 130 | 5 | gudmap_developingLowerUrinaryTract_P1_bladder_J_100_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#3_top-relative-expression-ranked_100 | 6.99e-07 | 28 | 130 | 5 | gudmap_developingLowerUrinaryTract_P1_bladder_B_100_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_100 | 9.85e-07 | 86 | 130 | 7 | gudmap_developingLowerUrinaryTract_P1_bladder_100_J | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_top-relative-expression-ranked_100 | 1.15e-06 | 88 | 130 | 7 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#3_top-relative-expression-ranked_100 | 1.74e-06 | 15 | 130 | 4 | gudmap_developingLowerUrinaryTract_P1_ureter_100_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#5_top-relative-expression-ranked_200 | 3.00e-06 | 17 | 130 | 4 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_200_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#4_top-relative-expression-ranked_100 | 4.84e-06 | 19 | 130 | 4 | gudmap_developingLowerUrinaryTract_adult_bladder_100_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#2_top-relative-expression-ranked_500 | 6.94e-06 | 115 | 130 | 7 | gudmap_developingLowerUrinaryTract_P1_bladder_B_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_top-relative-expression-ranked_100 | 9.04e-06 | 79 | 130 | 6 | gudmap_developingLowerUrinaryTract_adult_bladder_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_top-relative-expression-ranked_100 | 1.20e-05 | 83 | 130 | 6 | gudmap_developingLowerUrinaryTract_P1_bladder_100_B | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#2_top-relative-expression-ranked_200 | 1.35e-05 | 50 | 130 | 5 | gudmap_developingLowerUrinaryTract_P1_bladder_B_200_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#3_top-relative-expression-ranked_200 | 1.69e-05 | 88 | 130 | 6 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_200_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#3_top-relative-expression-ranked_100 | 1.83e-05 | 9 | 130 | 3 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_100_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#4_top-relative-expression-ranked_200 | 2.11e-05 | 27 | 130 | 4 | gudmap_developingLowerUrinaryTract_P1_ureter_200_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.17e-05 | 92 | 130 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.75e-05 | 142 | 130 | 7 | gudmap_developingKidney_e15.5_1000_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#4_top-relative-expression-ranked_200 | 3.71e-05 | 31 | 130 | 4 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_200_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#2_top-relative-expression-ranked_100 | 4.22e-05 | 32 | 130 | 4 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_100_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_top-relative-expression-ranked_1000 | VWF CYP2E1 DNAJC19 ACTA1 ACTA2 ACTC1 ACTG2 ERMP1 TENM2 POF1B RYR2 PGM5 PTPRB OSMR TNNT2 | 4.42e-05 | 734 | 130 | 15 | gudmap_developingLowerUrinaryTract_adult_bladder_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#4_top-relative-expression-ranked_500 | 5.11e-05 | 107 | 130 | 6 | gudmap_developingLowerUrinaryTract_adult_bladder_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_top-relative-expression-ranked_200 | 5.88e-05 | 160 | 130 | 7 | gudmap_developingLowerUrinaryTract_P1_bladder_200_B | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_200 | 6.12e-05 | 161 | 130 | 7 | gudmap_developingLowerUrinaryTract_P1_bladder_200_J | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#4_top-relative-expression-ranked_100 | 6.13e-05 | 13 | 130 | 3 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_100_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#5_top-relative-expression-ranked_200 | 6.54e-05 | 69 | 130 | 5 | gudmap_developingLowerUrinaryTract_P1_bladder_J_200_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_top-relative-expression-ranked_200 | 6.87e-05 | 164 | 130 | 7 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_200 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.57e-05 | 37 | 130 | 4 | gudmap_dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k3_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#4_top-relative-expression-ranked_200 | 9.34e-05 | 39 | 130 | 4 | gudmap_developingLowerUrinaryTract_adult_bladder_200_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#5_top-relative-expression-ranked_500 | 1.11e-04 | 77 | 130 | 5 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_top-relative-expression-ranked_100 | 1.33e-04 | 80 | 130 | 5 | gudmap_developingLowerUrinaryTract_P1_ureter_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_top-relative-expression-ranked_100 | 1.49e-04 | 82 | 130 | 5 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_k-means-cluster#3_top-relative-expression-ranked_100 | 1.71e-04 | 18 | 130 | 3 | gudmap_developingKidney_e15.5_Podocyte cells_100_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.83e-04 | 192 | 130 | 7 | gudmap_developingLowerUrinaryTract_P1_bladder_B_1000_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#1_top-relative-expression-ranked_500 | 1.86e-04 | 86 | 130 | 5 | gudmap_developingLowerUrinaryTract_P1_ureter_500_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_top-relative-expression-ranked_1000 | SLC9A9 AMPH KIF26B ACTA2 ACTC1 ACTG2 TENM2 PGM5 PTPRB CNTN3 OSMR TNNT2 RIMS2 CTSB FGF19 | 1.87e-04 | 836 | 130 | 15 | gudmap_developingKidney_e15.5_Podocyte cells_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#5_top-relative-expression-ranked_500 | 1.95e-04 | 47 | 130 | 4 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_200 | 2.02e-04 | 19 | 130 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_200_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#3_top-relative-expression-ranked_500 | 2.08e-04 | 88 | 130 | 5 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_500_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_500 | 2.66e-04 | 420 | 130 | 10 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_500 | |
| CoexpressionAtlas | UniversalReference_WholeMouseP1_top-relative-expression-ranked_250 | 2.82e-04 | 206 | 130 | 7 | Facebase_ST1_Univ_250 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.97e-04 | 95 | 130 | 5 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k4_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_top-relative-expression-ranked_200 | 3.89e-04 | 155 | 130 | 6 | gudmap_developingLowerUrinaryTract_P1_ureter_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | SEL1L SLC9A9 ERBB3 KIF26B ACTA1 ACTA2 ACTC1 ACTG2 PTCH1 TENM2 PGM5 LRIG3 CTSB CDH11 | 4.28e-04 | 806 | 130 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | ATG4A ACTA1 ACTA2 ACTC1 ACTG2 SERPINE2 PTPRB ADAMTS6 UGT8 CTH OSMR CTSB PLOD2 FGGY CDH11 | 4.34e-04 | 905 | 130 | 15 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.45e-04 | 159 | 130 | 6 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#4_top-relative-expression-ranked_500 | 4.51e-04 | 104 | 130 | 5 | gudmap_developingLowerUrinaryTract_P1_bladder_J_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_top-relative-expression-ranked_200 | 4.61e-04 | 160 | 130 | 6 | gudmap_developingLowerUrinaryTract_adult_bladder_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.61e-04 | 160 | 130 | 6 | gudmap_developingKidney_e15.5_Podocyte cells_1000_k3 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_500 | 4.74e-04 | 371 | 130 | 9 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_top-relative-expression-ranked_200 | 4.92e-04 | 162 | 130 | 6 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_200 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_top-relative-expression-ranked_1000 | AMPH KIF26B ACTA2 KDM6B PGM5 LRIG3 YPEL4 ADAMTS6 TXNRD3 CNTN3 CTH CDH11 | 5.21e-04 | 633 | 130 | 12 | gudmap_kidney_P1_CapMes_Crym_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_200 | 5.25e-04 | 164 | 130 | 6 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_top-relative-expression-ranked_500 | 5.42e-04 | 378 | 130 | 9 | gudmap_developingLowerUrinaryTract_adult_bladder_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_top-relative-expression-ranked_500 | 6.07e-04 | 384 | 130 | 9 | gudmap_developingLowerUrinaryTract_P1_bladder_500_B | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_1000 | EPHX2 VWF ERAP1 KIF26B PECAM1 ACTA2 ACTG2 RYR2 PGM5 PTPRB SGO2 TNNT2 TARS1 BRWD1 | 6.21e-04 | 837 | 130 | 14 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_500 | 6.53e-04 | 388 | 130 | 9 | gudmap_developingLowerUrinaryTract_P1_bladder_500_J | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#3_top-relative-expression-ranked_500 | 7.13e-04 | 115 | 130 | 5 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_500_k3 | |
| CoexpressionAtlas | BM Top 100 - saphenous vein | 8.52e-04 | 69 | 130 | 4 | BM Top 100 - saphenous vein | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_top-relative-expression-ranked_200 | 8.65e-04 | 120 | 130 | 5 | gudmap_kidney_P1_CapMes_Crym_200 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_Captopr_top-relative-expression-ranked_500 | 9.00e-04 | 406 | 130 | 9 | gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#2_top-relative-expression-ranked_1000 | 9.13e-04 | 251 | 130 | 7 | gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#2_top-relative-expression-ranked_1000 | 9.58e-04 | 184 | 130 | 6 | gudmap_developingLowerUrinaryTract_P1_ureter_1000_k2 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_top-relative-expression-ranked_200 | 1.00e-03 | 124 | 130 | 5 | gudmap_kidney_P0_CapMes_Crym_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#5_top-relative-expression-ranked_500 | 1.04e-03 | 187 | 130 | 6 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#3_top-relative-expression-ranked_500 | 1.05e-03 | 73 | 130 | 4 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k3_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#2_top-relative-expression-ranked_200 | 1.07e-03 | 33 | 130 | 3 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_200_k2 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_500 | 1.24e-03 | 130 | 130 | 5 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_k-means-cluster#2_top-relative-expression-ranked_200 | 1.27e-03 | 35 | 130 | 3 | gudmap_developingKidney_e15.5_Podocyte cells_200_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder urothelium (LCM)_emap-30380_k-means-cluster#4_top-relative-expression-ranked_500 | 1.27e-03 | 35 | 130 | 3 | gudmap_developingLowerUrinaryTract_P2_bladder urothelium (LCM)_500_k4 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.43e-08 | 160 | 136 | 8 | 8624f101828efd32cdd38a65df8d94d690720a63 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.43e-08 | 160 | 136 | 8 | 9de3dd6b9d4b51314d60b3b01f4132bcfa2dfc18 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 9.70e-08 | 183 | 136 | 8 | e84539978ab4de42e19186aed00f24bb50cbc21f | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-07 | 185 | 136 | 8 | d9be5853acdda7b1ac819cf50c7940d1d2362d15 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Interneuron|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 1.92e-07 | 200 | 136 | 8 | a6500d0d2e8bcac92381ab771dbdee66b0e1d48e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.71e-07 | 165 | 136 | 7 | a74751e0ec857aa974bec04ccc747c004a8f6e01 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.05e-07 | 169 | 136 | 7 | 88aa2246ede582c2e11de63228d76f520889ecb3 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.05e-07 | 169 | 136 | 7 | a6a5b00912b653fad2ca7f096deaf35c9ef85e5b | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.05e-07 | 169 | 136 | 7 | 42a9b8c77d2a4d68b01e4db38f8a1af53c9c814f | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.41e-07 | 170 | 136 | 7 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.79e-07 | 171 | 136 | 7 | 82de2885c8ce4fb7776da6a0207b3355c0910121 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.79e-07 | 171 | 136 | 7 | 09e653973962fb884878089d281f0947f7a285f6 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.23e-06 | 177 | 136 | 7 | 7ebdcedfe02da6d05bba3d625d8bd4c4ea96e4ad | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.43e-06 | 181 | 136 | 7 | 25915e2500430a902db37d79a749ce2990b69810 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.54e-06 | 183 | 136 | 7 | c1297d8eddfc7132e84ceef14f01b6281f9d0f6a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-06 | 184 | 136 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-06 | 184 | 136 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-06 | 184 | 136 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Bladder-nan-18m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-06 | 185 | 136 | 7 | 3e00879466e626aa8604efecfc4678d64f54dbfc | |
| ToppCell | facs-Bladder-nan-18m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-06 | 185 | 136 | 7 | 3dc5812c961ff209f197ff4cbfb90009c0537550 | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.72e-06 | 186 | 136 | 7 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.72e-06 | 186 | 136 | 7 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.72e-06 | 186 | 136 | 7 | e044b3428b7eacfdc72d0f57cdabaa1de04c74cd | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.78e-06 | 187 | 136 | 7 | 387cb27c8a20031cd87381a9e1172f1f62e1488b | |
| ToppCell | facs-Heart-LA-24m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-06 | 187 | 136 | 7 | d9943e65eedab73d141eae524e2411653a751705 | |
| ToppCell | facs-Heart-LA-24m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-06 | 187 | 136 | 7 | 7b13c3b67d66f3afb410141d5471c9e78a4d8623 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.84e-06 | 188 | 136 | 7 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.84e-06 | 188 | 136 | 7 | 3004e961d214919e08c7cd5f10c3de5cf85b35a3 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.91e-06 | 189 | 136 | 7 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.91e-06 | 189 | 136 | 7 | f75cebd4c3e54e297557449ba67ccc8d1a2a14f5 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.91e-06 | 189 | 136 | 7 | da9ecc0d7b81c1901f30f97bb44112dc85444a66 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.91e-06 | 189 | 136 | 7 | 0abc7a4900cc9033bc1be69b770ccc54a6bf41b4 | |
| ToppCell | facs-Heart-LA-24m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-06 | 190 | 136 | 7 | 911b93c4c828ef2d867b91a5eced2dc12a1baf27 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 2.12e-06 | 192 | 136 | 7 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-myocytic-myofibroblast|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.35e-06 | 195 | 136 | 7 | eb2003d4f15cad213d17eda8ab7479f5a0c62164 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-myocytic|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.35e-06 | 195 | 136 | 7 | 44f67437ea65d530133a0240b17f9860d9cc0e99 | |
| ToppCell | droplet-Heart-nan-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-06 | 196 | 136 | 7 | e386526332138e636aef2542c11316347a45689c | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-MYL4+_SMC|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.51e-06 | 197 | 136 | 7 | 4797f414330316e2ac2cf7cd2570d991877d7a38 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.60e-06 | 198 | 136 | 7 | 22e766df1276c5b14aa0d83f434f47140ebb98ea | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.69e-06 | 199 | 136 | 7 | bd43a84e84d8acb8e1008b98a235cc5bd5f43586 | |
| ToppCell | 11.5-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class | 2.69e-06 | 199 | 136 | 7 | 1a8c77d241bd817a195e1532fd25f51358cb1ff1 | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.78e-06 | 200 | 136 | 7 | a8b59e6fe04271fef61db911a286b5c48438bb84 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.78e-06 | 200 | 136 | 7 | c06426f877919bdd267ea2fd7e7973c6619832ae | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type | 2.78e-06 | 200 | 136 | 7 | 8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte|Control_saline / Treatment groups by lineage, cell group, cell type | 2.78e-06 | 200 | 136 | 7 | cb7ef774b6d300f8019c5b16a04e3ebd165e4f1c | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_3|Control_saline / Treatment groups by lineage, cell group, cell type | 2.78e-06 | 200 | 136 | 7 | b0866b497aa71d06cef25f9a335fa584e95fa7e0 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_only / Treatment groups by lineage, cell group, cell type | 2.78e-06 | 200 | 136 | 7 | 7c62678cf408aaaf98d6df0fb27814d2007c4521 | |
| ToppCell | severe_influenza-B_cell|World / disease group, cell group and cell class (v2) | 6.71e-06 | 86 | 136 | 5 | 7b595bcba4bcb72b7de7c06e19f690f0c739c529 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.87e-06 | 157 | 136 | 6 | 370f44047ef438b8f1124c2c2761c150c0d8c57f | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 9.53e-06 | 159 | 136 | 6 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.14e-05 | 164 | 136 | 6 | 3cd80e6275f0f9b5667912139d15ebf5e6b17f2f | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.22e-05 | 166 | 136 | 6 | 390cf5e56b72fcaf3b8520930bd35a3e3e173711 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.22e-05 | 166 | 136 | 6 | 9a341dc7b756252caeaac1e934384911c880a634 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.26e-05 | 167 | 136 | 6 | d78356bf0c473816dbabaee51984940bd822f84e | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 168 | 136 | 6 | 2e88d9cb7c80a4656fab290db8b45a5a0599d769 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-05 | 169 | 136 | 6 | c7fc3a8c44f07c557b60d469717b66e2f5863d38 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-05 | 169 | 136 | 6 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 1.39e-05 | 170 | 136 | 6 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_activated|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.39e-05 | 170 | 136 | 6 | 513d9036aa41d4d902da8baa66a66206abb6f3b0 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.44e-05 | 171 | 136 | 6 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.49e-05 | 172 | 136 | 6 | de9b11ab109d04937186c09772cec9105a935f95 | |
| ToppCell | facs-Heart-LV-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-05 | 172 | 136 | 6 | f2c17c49b375b28ad47dc6cabda62f1c238023dd | |
| ToppCell | facs-Heart-LV-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-05 | 172 | 136 | 6 | 6ab4f01098dddb789df298ddf97b3c384405ee6c | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.49e-05 | 172 | 136 | 6 | 8a6a2b4c6654bc976e60a02d0e7303a9071ed55f | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.64e-05 | 175 | 136 | 6 | d43ae33a6256606ce848247cad32d74f21b38988 | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.70e-05 | 176 | 136 | 6 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-OMD+_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.70e-05 | 176 | 136 | 6 | 52af8f717dbd3b59eeb868b8b7b256a8f3e57d7a | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.75e-05 | 177 | 136 | 6 | 5ff8dcfb030312126695d53a026d2e104a401b83 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.75e-05 | 177 | 136 | 6 | c9b02a2e1ff2aa18c37e88a53b06a5b696a442ae | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-1|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.81e-05 | 178 | 136 | 6 | 812e261d9cbdc74fafe3c5c3422151c1cfacb22d | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.87e-05 | 179 | 136 | 6 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-05 | 180 | 136 | 6 | af2bafcd1b2082629de3ea336711add01565c4c4 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-05 | 180 | 136 | 6 | f29a995cf6e1a1836ed68b73258d9370bf3d4434 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.99e-05 | 181 | 136 | 6 | d7e04e0ca549eac6d9b1192b6578f9b54943d54f | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.99e-05 | 181 | 136 | 6 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-05 | 181 | 136 | 6 | 4ea02344e1996f264dd5e14f3b19c8782ce41699 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.05e-05 | 182 | 136 | 6 | 41b070085edba7a58b81c20aa4942d06f745acf8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.05e-05 | 182 | 136 | 6 | 5e9a67b2de0daa4fdc344b10a857d8a901ad810e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.05e-05 | 182 | 136 | 6 | b0fe042c71d6ab8c75abd7ba9d2de00b72d01c0c | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-05 | 182 | 136 | 6 | aa113a0d2c1d28bda24cbb1221afd21b5628dc6d | |
| ToppCell | Pericytes-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 2.12e-05 | 183 | 136 | 6 | d04deef7cd4e1738227a6593b84874ce0168c773 | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-05 | 183 | 136 | 6 | 6c4a09c02e30e1f24dde39f8cb8c5b453826ee2e | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.12e-05 | 183 | 136 | 6 | ce8be9418b473ea94ec806edc7a2078cc30c1703 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-05 | 183 | 136 | 6 | 6f5dbac2748f50105f0f548d189c42ef14287019 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-myocytic-myofibroblast|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.12e-05 | 183 | 136 | 6 | 6b5eef96b28911c752a8b6c0975918c4572cec38 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-05 | 183 | 136 | 6 | b0b5a41f1a40f9c946d0dc8b67eaccdd9f9b73a5 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-05 | 184 | 136 | 6 | f17d713af4a97dff4eeeab24c405677ef2ffcf84 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.18e-05 | 184 | 136 | 6 | 16ed515fb673a9d6973133afcda0a3fba4a8d9dc | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-myocytic|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.18e-05 | 184 | 136 | 6 | 5cfc19ffb9f074bdf0d81c86e212a708ec141631 | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.18e-05 | 184 | 136 | 6 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.25e-05 | 185 | 136 | 6 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.25e-05 | 185 | 136 | 6 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.25e-05 | 185 | 136 | 6 | a7ae76058b2082020cadec49d63b9f4e24d21734 | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-05 | 186 | 136 | 6 | aa88d9573a237b2b8e6025fee31f69fbce824497 | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-05 | 186 | 136 | 6 | ecc5acd111a6ee50d59544d1bdd7ed94e2812aae | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.32e-05 | 186 | 136 | 6 | 7def03dd856b765bd3f493288641981c4f7fd26e | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-05 | 186 | 136 | 6 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.32e-05 | 186 | 136 | 6 | 26458ff8cad5577de4306cffa0ca69eb26940e0d | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.32e-05 | 186 | 136 | 6 | a71397efc68d2916ddc373d92cfd07be58033e1c | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.32e-05 | 186 | 136 | 6 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| Computational | Muscle genes. | 8.73e-06 | 37 | 83 | 5 | MODULE_512 | |
| Computational | Genes in the cancer module 387. | 3.55e-05 | 49 | 83 | 5 | MODULE_387 | |
| Computational | Genes in the cancer module 329. | 4.32e-05 | 51 | 83 | 5 | MODULE_329 | |
| Drug | 3-methylhistidine | 3.71e-08 | 55 | 136 | 7 | CID000064969 | |
| Drug | 1,N6-ethenoadenosine 5'-diphosphate | 4.77e-08 | 34 | 136 | 6 | CID000001312 | |
| Drug | Nsc687160 | 5.68e-08 | 18 | 136 | 5 | CID005459290 | |
| Drug | tolytoxin | 7.68e-08 | 19 | 136 | 5 | CID006440827 | |
| Drug | manidipine | 1.03e-07 | 95 | 136 | 8 | CID000004008 | |
| Drug | NSC312786 | 1.33e-07 | 21 | 136 | 5 | CID000329495 | |
| Drug | AC1L8NVR | 1.33e-07 | 21 | 136 | 5 | CID000384633 | |
| Drug | epsilon-ATP | 1.54e-07 | 41 | 136 | 6 | CID000162262 | |
| Drug | Tiabendazole [148-79-8]; Up 200; 19.8uM; HL60; HT_HG-U133A | 3.24e-07 | 198 | 136 | 10 | 2479_UP | |
| Drug | NpCaM | 4.06e-07 | 48 | 136 | 6 | CID000122259 | |
| Drug | HU-211 | 4.26e-07 | 114 | 136 | 8 | CID000107778 | |
| Drug | AC1L9EF8 | 4.71e-07 | 79 | 136 | 7 | CID000443315 | |
| Drug | azaspiracid | 8.93e-07 | 30 | 136 | 5 | CID006451158 | |
| Drug | pyrene | 1.23e-06 | 131 | 136 | 8 | CID000031423 | |
| Drug | AC1L1HS4 | 1.25e-06 | 32 | 136 | 5 | CID000004267 | |
| Drug | N,N'-p-phenylenedimaleimide | 1.71e-06 | 34 | 136 | 5 | CID000076765 | |
| Drug | AC1NRBPQ | 1.72e-06 | 137 | 136 | 8 | CID005288569 | |
| Drug | NSC3096 | 2.04e-06 | 98 | 136 | 7 | CID000002832 | |
| Drug | AC1L1JYL | STAG1 ACTBL2 PECAM1 ACTA1 ACTA2 ACTC1 ACTG2 SIRT6 RGS3 POF1B PIK3C3 MTOR UGT8 | 2.12e-06 | 434 | 136 | 13 | CID000005262 |
| Drug | 0-to | 2.14e-06 | 141 | 136 | 8 | CID000002051 | |
| Drug | AC1NQAAM | 2.51e-06 | 144 | 136 | 8 | CID005192834 | |
| Drug | NSC3260 | 2.71e-06 | 195 | 136 | 9 | CID000220461 | |
| Drug | 5-IAF | 2.75e-06 | 66 | 136 | 6 | CID000123822 | |
| Drug | Gemfibrozil [25812-30-0]; Down 200; 16uM; MCF7; HT_HG-U133A | 2.94e-06 | 197 | 136 | 9 | 2277_DN | |
| Drug | carbodiimide | 3.57e-06 | 151 | 136 | 8 | CID000009864 | |
| Drug | AC1OAGGW | 3.76e-06 | 203 | 136 | 9 | CID006857364 | |
| Drug | m2-19 | 4.40e-06 | 19 | 136 | 4 | CID000079129 | |
| Drug | blebbistatin | 6.30e-06 | 116 | 136 | 7 | CID003476986 | |
| Drug | AC1L8FNU | 6.36e-06 | 44 | 136 | 5 | CID000425429 | |
| Drug | TCNB | 7.46e-06 | 119 | 136 | 7 | CID000008330 | |
| Drug | guanosine 3',5'-cyclic monophosphoric acid | SLC25A18 ACTA1 ACTA2 ACTC1 ACTG2 GRIN2B SIRT6 EZH2 RYR1 RYR2 RCOR1 KCNA3 SLC24A2 TXNRD3 | 9.62e-06 | 577 | 136 | 14 | CID000000295 |
| Drug | AC1Q6LQU | 9.84e-06 | 48 | 136 | 5 | CID000072380 | |
| Drug | thalidomide | 9.97e-06 | 229 | 136 | 9 | CID000005426 | |
| Drug | formamide | 1.21e-05 | 85 | 136 | 6 | CID000000713 | |
| Drug | D-myo-inositol 1,4-bisphosphate | 1.29e-05 | 86 | 136 | 6 | CID000000805 | |
| Drug | NSC613009 | 1.33e-05 | 130 | 136 | 7 | CID000003800 | |
| Drug | sodium | SLC9A9 KCNH7 ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 SIRT6 CPT1B RYR1 RYR2 KCNA3 PTPRB SLC24A2 MTOR MTR ATP1A4 SMURF2 | 1.35e-05 | 944 | 136 | 18 | CID000000923 |
| Drug | Dopamine | 1.45e-05 | 240 | 136 | 9 | ctd:D004298 | |
| Drug | carbachol | MYH4 ERBB3 ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 SIRT6 CPT1B RGS3 RYR1 RYR2 PIK3C3 HPS4 CTSB | 1.61e-05 | 688 | 136 | 15 | CID000002551 |
| Drug | enantio-PAF-C16 | 1.65e-05 | 244 | 136 | 9 | CID000002499 | |
| Drug | AC1L22RD | 1.79e-05 | 91 | 136 | 6 | CID000065183 | |
| Drug | 6-trans-leukotriene B4 | 1.82e-05 | 247 | 136 | 9 | CID000000169 | |
| Drug | C18:1n-7 | 1.90e-05 | 92 | 136 | 6 | CID000122325 | |
| Drug | PTK/ZK | 2.11e-05 | 56 | 136 | 5 | CID000151193 | |
| Drug | AC1OAGKW | 2.15e-05 | 193 | 136 | 8 | CID006857413 | |
| Drug | NSC60597 | 2.16e-05 | 140 | 136 | 7 | CID000003327 | |
| Drug | NSC717865 | AOC1 ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 DPM1 RYR1 RYR2 MTOR HPS4 | 2.17e-05 | 387 | 136 | 11 | CID000005372 |
| Drug | CID5288653 | 2.23e-05 | 28 | 136 | 4 | CID005288653 | |
| Drug | Rp-cAMPS | 2.23e-05 | 194 | 136 | 8 | CID006426631 | |
| Drug | (2S,3R)-Sphingosine | ERBB3 STAG1 ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 SIRT6 RYR1 RYR2 UGT8 | 2.27e-05 | 389 | 136 | 11 | CID000001104 |
| Drug | Xylazine [7361-61-7]; Up 200; 18.2uM; HL60; HT_HG-U133A | 2.32e-05 | 195 | 136 | 8 | 2132_UP | |
| Drug | Trimeprazine tartrate [4330-99-8]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 2.32e-05 | 195 | 136 | 8 | 3478_UP | |
| Drug | AH6809; Down 200; 1uM; PC3; HT_HG-U133A | 2.40e-05 | 196 | 136 | 8 | 7049_DN | |
| Drug | ICI182,780; Down 200; 1uM; PC3; HT_HG-U133A | 2.49e-05 | 197 | 136 | 8 | 6867_DN | |
| Drug | dihydrocytochalasin B | 2.51e-05 | 58 | 136 | 5 | CID000003064 | |
| Drug | retinoic acid; Down 200; 1uM; PC3; HT_HG-U133A | 2.58e-05 | 198 | 136 | 8 | 4435_DN | |
| Drug | sodium nitroprusside | 2.81e-05 | 261 | 136 | 9 | CID000045469 | |
| Drug | phorbol acetate myristate | ERBB3 CYP2E1 ACTBL2 PECAM1 ACTA1 ACTA2 ACTC1 ACTG2 SIRT6 CPT1B KDM6B CPT2 CR2 ADAM10 RYR1 RYR2 LGALS4 KCNA3 PIK3C3 MTOR TNNT2 CTSB | 2.82e-05 | 1399 | 136 | 22 | CID000004792 |
| Drug | vandetanib | 2.89e-05 | 99 | 136 | 6 | CID003081361 | |
| Drug | fluorescein isothiocyanate | 2.95e-05 | 147 | 136 | 7 | CID000018730 | |
| Drug | sulphoxide | 3.24e-05 | 101 | 136 | 6 | CID000008442 | |
| Drug | 2-Amino-4- | 3.32e-05 | 11 | 136 | 3 | CID006326973 | |
| Drug | Isoproterenol | VWF AOC1 CYP2E1 ACTA1 ACTA2 ACTG2 CPT1B KDM6B CPT2 RYR2 MTOR OSMR TNNT2 CTSB SMURF2 CDH11 DNMT3A BRWD1 | 3.58e-05 | 1016 | 136 | 18 | ctd:D007545 |
| Drug | oryzalin | 3.76e-05 | 63 | 136 | 5 | CID000029393 | |
| Drug | bumetanide | 3.80e-05 | 209 | 136 | 8 | CID000002471 | |
| Drug | M3/M4 | 3.85e-05 | 32 | 136 | 4 | CID000486507 | |
| Drug | DFMO | 4.14e-05 | 155 | 136 | 7 | CID000003009 | |
| Drug | isocitrate | 4.32e-05 | 156 | 136 | 7 | CID000001198 | |
| Drug | LMWH | CPAMD8 ERBB3 VWF AOC1 ACTA1 ACTA2 ACTC1 ACTG2 RYR1 RYR2 SERPINE2 KCNA3 TNNT2 FGF19 | 4.44e-05 | 663 | 136 | 14 | CID000000772 |
| Drug | Curcumin | ERBB3 VWF AOC1 RIPK1 CYP2E1 PECAM1 ACTA2 PGD SERPINE2 MTOR OSMR RIMS2 CTSB PLOD2 CDH11 DNMT3A | 4.93e-05 | 850 | 136 | 16 | ctd:D003474 |
| Drug | Ro-1724 | 5.24e-05 | 110 | 136 | 6 | CID000005087 | |
| Drug | S-adenosylmethionine | 5.59e-05 | 355 | 136 | 10 | CID000001079 | |
| Drug | dithiotreitol | 5.64e-05 | 430 | 136 | 11 | CID000019001 | |
| Drug | S-adenosyl-D-homocysteine | 5.82e-05 | 222 | 136 | 8 | CID000000193 | |
| Drug | AC1L1ERT | 5.84e-05 | 69 | 136 | 5 | CID000002920 | |
| Drug | SB203580 | ERBB3 VWF CYP2E1 PPM1D ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 SIRT6 LGALS4 PIK3C3 MTOR IL22 OSMR | 5.95e-05 | 771 | 136 | 15 | CID000176155 |
| Drug | AC1NSKFN | 6.18e-05 | 36 | 136 | 4 | CID005311324 | |
| Drug | auxin | 6.19e-05 | 224 | 136 | 8 | CID000000801 | |
| Drug | caged ATP | 6.26e-05 | 70 | 136 | 5 | CID000123806 | |
| Drug | 1tjp | 7.04e-05 | 116 | 136 | 6 | CID005459371 | |
| Drug | B0683 | 7.39e-05 | 117 | 136 | 6 | CID006398969 | |
| Drug | nitric oxide | VWF CYP2E1 PPM1D ACTBL2 PECAM1 ACTA1 ACTA2 ACTC1 ACTG2 GRIN2B RYR1 RYR2 ADO IL22 MTR CTH CTSB NNT | 7.40e-05 | 1075 | 136 | 18 | CID000145068 |
| Drug | Y-27632 | CAPN12 ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 SIRT6 ADAM10 LGALS4 PIK3C3 CTSB | 7.51e-05 | 444 | 136 | 11 | CID000005711 |
| Drug | H2O2 | ERBB3 AMPH AOC1 CYP2E1 PPM1D ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 SIRT6 RYR1 RYR2 RCOR1 PIK3C3 MTOR TXNRD3 CTSV CDH11 | 7.99e-05 | 1183 | 136 | 19 | CID000000784 |
| Drug | AC1L1DXE | 8.04e-05 | 299 | 136 | 9 | CID000002548 | |
| Drug | protocatechuic acid | 8.12e-05 | 119 | 136 | 6 | CID000000072 | |
| Drug | peroxynitrite | CYP2E1 ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 GRIN2B RYR1 RYR2 TXNRD3 | 8.43e-05 | 373 | 136 | 10 | CID000104806 |
| Drug | 5'-N-ethylcarboxamidoadenosine | 8.61e-05 | 174 | 136 | 7 | CID000104795 | |
| Drug | AC1LD8HW | 8.72e-05 | 75 | 136 | 5 | CID000644061 | |
| Drug | AC1L1IZ2 | 9.12e-05 | 304 | 136 | 9 | CID000004795 | |
| Drug | pentoxifylline | CYP2E1 ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 HS1BP3 SERPINE2 PIK3C3 | 9.12e-05 | 304 | 136 | 9 | CID000004740 |
| Drug | Formyl | 9.45e-05 | 238 | 136 | 8 | CID000123370 | |
| Drug | Les T | 9.75e-05 | 123 | 136 | 6 | CID000003189 | |
| Drug | 8-bromoguanosine 3',5'-cyclic monophosphate | 1.01e-04 | 308 | 136 | 9 | CID000001915 | |
| Drug | AC1L1KC5 | ERBB3 ACTBL2 ACTA1 ACTA2 ACTC1 ACTG2 SIRT6 RYR1 RYR2 KCNA3 PIK3C3 CTSB | 1.01e-04 | 541 | 136 | 12 | CID000005428 |
| Drug | cis-diammineplatinum(II | 1.06e-04 | 3 | 136 | 2 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 1.06e-04 | 3 | 136 | 2 | CID002750949 | |
| Drug | 8N3-cADPR | 1.06e-04 | 3 | 136 | 2 | CID000127713 | |
| Drug | aminodantrolene | 1.06e-04 | 3 | 136 | 2 | CID009570289 | |
| Drug | 2-hydroxycarbazole | 1.06e-04 | 3 | 136 | 2 | CID000093551 | |
| Disease | Moyamoya disease (implicated_via_orthology) | 1.90e-13 | 8 | 131 | 6 | DOID:13099 (implicated_via_orthology) | |
| Disease | autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology) | 1.90e-13 | 8 | 131 | 6 | DOID:0110550 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome 1 (implicated_via_orthology) | 1.90e-13 | 8 | 131 | 6 | DOID:0081112 (implicated_via_orthology) | |
| Disease | thoracic aortic aneurysm (implicated_via_orthology) | 1.90e-13 | 8 | 131 | 6 | DOID:14004 (implicated_via_orthology) | |
| Disease | intestinal atresia (implicated_via_orthology) | 1.41e-12 | 10 | 131 | 6 | DOID:10486 (implicated_via_orthology) | |
| Disease | patent ductus arteriosus (implicated_via_orthology) | 1.41e-12 | 10 | 131 | 6 | DOID:13832 (implicated_via_orthology) | |
| Disease | Moyamoya disease 1 | 1.96e-05 | 2 | 131 | 2 | C2931384 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.76e-05 | 195 | 131 | 7 | DOID:1574 (implicated_via_orthology) | |
| Disease | Cardiomegaly | 3.31e-05 | 82 | 131 | 5 | C0018800 | |
| Disease | Cardiac Hypertrophy | 3.31e-05 | 82 | 131 | 5 | C1383860 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 3.74e-05 | 15 | 131 | 3 | C0496930 | |
| Disease | Benign neoplasm of bladder | 3.74e-05 | 15 | 131 | 3 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 3.74e-05 | 15 | 131 | 3 | C0154091 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 5.85e-05 | 3 | 131 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 5.85e-05 | 3 | 131 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | Carcinoma of bladder | 6.65e-05 | 18 | 131 | 3 | C0699885 | |
| Disease | colorectal adenoma (is_marker_for) | 9.22e-05 | 20 | 131 | 3 | DOID:0050860 (is_marker_for) | |
| Disease | Dowling-Degos disease 1 | 1.17e-04 | 4 | 131 | 2 | C4552092 | |
| Disease | Reticulate acropigmentation of Kitamura | 1.17e-04 | 4 | 131 | 2 | C0406811 | |
| Disease | Hypertrophic Cardiomyopathy | 1.22e-04 | 57 | 131 | 4 | C0007194 | |
| Disease | dowling-degos disease | 1.94e-04 | 5 | 131 | 2 | C3714534 | |
| Disease | Moyamoya disease (is_implicated_in) | 1.94e-04 | 5 | 131 | 2 | DOID:13099 (is_implicated_in) | |
| Disease | chronic myeloid leukemia (is_marker_for) | 2.31e-04 | 27 | 131 | 3 | DOID:8552 (is_marker_for) | |
| Disease | Congenital myopathy with fiber type disproportion | 2.90e-04 | 6 | 131 | 2 | cv:C0546264 | |
| Disease | Leukemia, Myelomonocytic, Chronic | 2.90e-04 | 6 | 131 | 2 | C0023480 | |
| Disease | stomach cancer (is_implicated_in) | 3.02e-04 | 72 | 131 | 4 | DOID:10534 (is_implicated_in) | |
| Disease | Ovarian Mucinous Adenocarcinoma | 3.51e-04 | 31 | 131 | 3 | C1335167 | |
| Disease | intraocular pressure measurement | SEL1L STAG1 ATP13A2 KLHL38 ZNF106 ADAMTS6 MTOR FAM186A CDH11 | 4.65e-04 | 509 | 131 | 9 | EFO_0004695 |
| Disease | nemaline myopathy (implicated_via_orthology) | 5.38e-04 | 8 | 131 | 2 | DOID:3191 (implicated_via_orthology) | |
| Disease | Autism Spectrum Disorders | 5.69e-04 | 85 | 131 | 4 | C1510586 | |
| Disease | Mammary Carcinoma, Human | 5.80e-04 | 525 | 131 | 9 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 5.80e-04 | 525 | 131 | 9 | C1257931 | |
| Disease | colorectal carcinoma (is_marker_for) | 5.95e-04 | 37 | 131 | 3 | DOID:0080199 (is_marker_for) | |
| Disease | Mammary Neoplasms | 5.96e-04 | 527 | 131 | 9 | C1458155 | |
| Disease | Breast Carcinoma | 6.90e-04 | 538 | 131 | 9 | C0678222 | |
| Disease | epilepsy (implicated_via_orthology) | 8.22e-04 | 163 | 131 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | metabolite measurement | 9.14e-04 | 560 | 131 | 9 | EFO_0004725 | |
| Disease | Tachycardia, Ventricular | 1.05e-03 | 11 | 131 | 2 | C0042514 | |
| Disease | Cardiomyopathy, Dilated | 1.28e-03 | 48 | 131 | 3 | C0007193 | |
| Disease | cortical thickness | CPAMD8 ERBB3 PTCH1 MAST2 ADAM10 ATP13A2 TENM2 KLHL38 ZNF106 UTP4 CTBP2 OSMR CDH11 | 1.39e-03 | 1113 | 131 | 13 | EFO_0004840 |
| Disease | Cardiomyopathy, Familial Idiopathic | 1.44e-03 | 50 | 131 | 3 | C1449563 | |
| Disease | Autosomal Dominant Myotubular Myopathy | 1.48e-03 | 13 | 131 | 2 | C3661489 | |
| Disease | Centronuclear myopathy | 1.48e-03 | 13 | 131 | 2 | C0175709 | |
| Disease | liver cirrhosis (implicated_via_orthology) | 1.48e-03 | 13 | 131 | 2 | DOID:5082 (implicated_via_orthology) | |
| Disease | X-linked centronuclear myopathy | 1.48e-03 | 13 | 131 | 2 | C0410203 | |
| Disease | Myopathy, Centronuclear, 1 | 1.48e-03 | 13 | 131 | 2 | C4551952 | |
| Disease | Congenital Structural Myopathy | 1.48e-03 | 13 | 131 | 2 | C0752282 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 1.54e-03 | 111 | 131 | 4 | EFO_0004530, EFO_0008595 | |
| Disease | Myopathy, Centronuclear, Autosomal Dominant | 1.72e-03 | 14 | 131 | 2 | C1834558 | |
| Disease | Tubular Aggregate Myopathy | 1.72e-03 | 14 | 131 | 2 | C0410207 | |
| Disease | asthma, body mass index | 1.72e-03 | 14 | 131 | 2 | EFO_0004340, MONDO_0004979 | |
| Disease | intracranial aneurysm (is_marker_for) | 1.72e-03 | 14 | 131 | 2 | DOID:10941 (is_marker_for) | |
| Disease | Left ventricular noncompaction | 1.72e-03 | 14 | 131 | 2 | C1960469 | |
| Disease | neuroimaging measurement, brain volume measurement | 1.79e-03 | 286 | 131 | 6 | EFO_0004346, EFO_0006930 | |
| Disease | pulmonary hypertension (implicated_via_orthology) | 1.80e-03 | 54 | 131 | 3 | DOID:6432 (implicated_via_orthology) | |
| Disease | Necrosis | 1.90e-03 | 55 | 131 | 3 | C0027540 | |
| Disease | Lymphoma, Follicular, Grade 2 | 1.98e-03 | 15 | 131 | 2 | C1956132 | |
| Disease | Lymphoma, Follicular, Grade 3 | 1.98e-03 | 15 | 131 | 2 | C1956131 | |
| Disease | Lymphoma, Follicular, Grade 1 | 1.98e-03 | 15 | 131 | 2 | C1956130 | |
| Disease | Lymphoma, Large-Cell, Follicular | 1.98e-03 | 15 | 131 | 2 | C0079745 | |
| Disease | Lymphoma, Small Cleaved-Cell, Follicular | 1.98e-03 | 15 | 131 | 2 | C0079765 | |
| Disease | Lymphoma, Mixed-Cell, Follicular | 1.98e-03 | 15 | 131 | 2 | C0079758 | |
| Disease | nasopharynx carcinoma (is_implicated_in) | 1.98e-03 | 15 | 131 | 2 | DOID:9261 (is_implicated_in) | |
| Disease | Autosomal Recessive Centronuclear Myopathy | 1.98e-03 | 15 | 131 | 2 | C3645536 | |
| Disease | coronary thrombosis, GM11992 | 2.25e-03 | 16 | 131 | 2 | EFO_0001124, EFO_1000883 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 2.31e-03 | 301 | 131 | 6 | DOID:684 (is_marker_for) | |
| Disease | body surface area | 2.35e-03 | 643 | 131 | 9 | EFO_0022196 | |
| Disease | Moyamoya Disease | 2.55e-03 | 17 | 131 | 2 | C0026654 | |
| Disease | otitis media (biomarker_via_orthology) | 2.55e-03 | 17 | 131 | 2 | DOID:10754 (biomarker_via_orthology) | |
| Disease | cortical surface area measurement | USP34 SLC9A9 CPAMD8 ERBB3 STAG1 KIF26B PTCH1 MAST2 ATP13A2 TENM2 FOCAD ZNF106 CTBP2 CDH11 | 2.66e-03 | 1345 | 131 | 14 | EFO_0010736 |
| Disease | Congenital Fiber Type Disproportion | 2.86e-03 | 18 | 131 | 2 | C0546264 | |
| Disease | fat body mass | 2.89e-03 | 217 | 131 | 5 | EFO_0005409 | |
| Disease | non-alcoholic fatty liver disease (biomarker_via_orthology) | 3.06e-03 | 65 | 131 | 3 | DOID:0080208 (biomarker_via_orthology) | |
| Disease | polycystic kidney disease (biomarker_via_orthology) | 3.18e-03 | 19 | 131 | 2 | DOID:0080322 (biomarker_via_orthology) | |
| Disease | Juvenile Myelomonocytic Leukemia | 3.18e-03 | 19 | 131 | 2 | C0349639 | |
| Disease | fatty acid measurement | 3.41e-03 | 436 | 131 | 7 | EFO_0005110 | |
| Disease | vital capacity | USP34 AOC1 EPB41L4B PTCH1 MDM4 ATP13A2 TENM2 RYR2 ZNF106 ADAMTS6 FOLH1B NNT SMURF2 | 3.45e-03 | 1236 | 131 | 13 | EFO_0004312 |
| Disease | Profound Mental Retardation | 3.48e-03 | 139 | 131 | 4 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 3.48e-03 | 139 | 131 | 4 | C0025363 | |
| Disease | Mental deficiency | 3.48e-03 | 139 | 131 | 4 | C0917816 | |
| Disease | Fetal Growth Retardation | 3.53e-03 | 20 | 131 | 2 | C0015934 | |
| Disease | citrulline measurement | 3.53e-03 | 20 | 131 | 2 | EFO_0009777 | |
| Disease | Lymphoma, Follicular | 3.53e-03 | 20 | 131 | 2 | C0024301 | |
| Disease | phospholipid measurement | 3.57e-03 | 140 | 131 | 4 | EFO_0004639 | |
| Disease | osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty | 3.89e-03 | 21 | 131 | 2 | EFO_0004616, EFO_0010726, EFO_1000786 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 3.92e-03 | 71 | 131 | 3 | DOID:0050700 (implicated_via_orthology) | |
| Disease | obesity (biomarker_via_orthology) | 4.25e-03 | 147 | 131 | 4 | DOID:9970 (biomarker_via_orthology) | |
| Disease | Primary familial hypertrophic cardiomyopathy | 4.26e-03 | 22 | 131 | 2 | cv:C0949658 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VQIAKGMYYLEEHGM | 816 | P21860 | |
| YKAILAAGSMMQTHG | 236 | Q96RK4 | |
| RHLGKMYSEMIFVNG | 296 | Q86TW2 | |
| YSIHQMAQMGVGEGK | 126 | Q8WYN0 | |
| LYKSGVYQHVTGEMM | 261 | P07858 | |
| KVLNEAVGAMMYHTI | 71 | P56545 | |
| TVGMVRHQGKIMYVG | 671 | Q9Y6K1 | |
| RHQGVMVGMGQKDSY | 41 | P68133 | |
| HQGVMVGMGQKDCYV | 41 | Q562R1 | |
| MKMIELHNGEYSQGK | 56 | O60911 | |
| HSVFERMRKYQMTGV | 176 | O14672 | |
| GMHGMLKVLYGTVRI | 116 | Q96SZ5 | |
| VNMSKYDAARHGIIM | 1951 | Q86UK0 | |
| QGMMEGMHQKESYVG | 41 | Q9BYX7 | |
| RHQGVMVGMGQKDSY | 41 | P62736 | |
| TKYMNGHSDVVMGLV | 211 | P32929 | |
| HFVKMVHNGIEYGDM | 181 | P52209 | |
| HQGVMVGMGQKDSYV | 41 | P63267 | |
| PNGVMEAKMHATGYV | 471 | P19801 | |
| MKHATGNYIIIMDAD | 106 | O60762 | |
| DMLAAASKYRHGNMV | 386 | Q7Z2K6 | |
| VVADKMMVGYHGRKD | 256 | Q9UKP5 | |
| RGYLAAIKGMQEASM | 61 | P49418 | |
| GELQQMMVECSKYHG | 526 | P23786 | |
| AKEKHGYNMEQALGM | 156 | Q9UKL0 | |
| IMVKRAYETMAGAGV | 556 | O94776 | |
| HGEGKMMQYNVSIKV | 371 | Q99650 | |
| RLMKTVQTMKGHGNY | 511 | P49796 | |
| YVGSQRMVVMHGYKA | 71 | P05181 | |
| MSVYIQGVASEHMKR | 31 | P56470 | |
| KALMLAMGYHEKGRA | 231 | Q9Y5A7 | |
| RIDAMHGVMGPYVRK | 226 | Q15124 | |
| MMAEVVRRKLGTHYQ | 76 | Q8NBL1 | |
| YPGMAHRMQKEIAAL | 1006 | A5A3E0 | |
| TMIRGMVKHRAYEQA | 261 | Q96EY7 | |
| QGRMYKMVIVTHSGE | 1146 | P23467 | |
| DVHFNVKMMYLGVGV | 191 | Q9Y585 | |
| GAQGEMFTVKEVMHY | 41 | O15151 | |
| MENYAHLRAQGGEVM | 546 | Q6UXM1 | |
| SGTARYHMQMLRVKE | 671 | Q9NS40 | |
| HIYQYRMEKSGKGGM | 686 | Q2KJY2 | |
| DAAYMGRMDLHGKVG | 256 | Q5XKE5 | |
| MGLVRMNLYTHCVKG | 536 | Q9NQG7 | |
| VGHTILGMNTVQLYM | 1366 | O15054 | |
| NVHMKQEHYMKGSDG | 541 | Q9NZ08 | |
| YAKVMMVNGDHRIGI | 696 | Q15910 | |
| ALGRMVYVNKMTGLS | 1051 | Q9UHC1 | |
| NKAVYSVMAMVEHSG | 286 | P16284 | |
| HSVRYLCMGADGKMQ | 96 | O95750 | |
| MFKYHLTVAQVRGGM | 261 | Q9HBA9 | |
| KIIQTYEMMIVRHGF | 1516 | Q6ZR08 | |
| KSEYMVIEEGGMNHS | 526 | P22001 | |
| QLAMVMRYGVNGVGK | 76 | P07093 | |
| YTMMGATENYKHRGI | 101 | Q9HAQ2 | |
| SVVIIRGMKMYVAHV | 176 | O15297 | |
| RGMKMYVAHVGDSGV | 181 | O15297 | |
| IGNHYTEMVKNLRME | 456 | Q8WVV4 | |
| KAMSHMLCIGYGRQA | 471 | Q9Y3Q4 | |
| GGQKVRLMKEVMEHY | 86 | O00469 | |
| YGRMDHKSFMGVAQI | 1346 | Q9UQ26 | |
| YPGMAHRMQKEIAAL | 1006 | Q6S8J3 | |
| RVIGYHVVVWMMAGI | 46 | Q9NQ11 | |
| AKLHGSYEVMRGGHM | 186 | Q6ZSI9 | |
| SYEVMRGGHMNEAFV | 191 | Q6ZSI9 | |
| KYVGGDQFGHVNMVM | 116 | Q9H6K1 | |
| LAQAGYRVLAMDMKG | 281 | P34913 | |
| RGKMMSGHVEYQILV | 31 | Q53T59 | |
| QRALDYGVQAGMKMI | 36 | Q8NFQ6 | |
| MHMENNVVCIRYKGE | 421 | Q9H4Z3 | |
| VNGKHTGMMAENFLY | 726 | P20023 | |
| GKIIQIYEMMLVRHG | 1691 | Q8TD57 | |
| HSVLQYVGGVMSVEM | 131 | Q96C11 | |
| LQNQHGKAMYKGMID | 36 | Q9H1K4 | |
| VEKAMGNEMSAHQYL | 591 | Q96ST8 | |
| KHMGMKRYEVAGRRV | 1596 | Q8IZJ3 | |
| FGDTDMYHRAQKMGT | 346 | Q9NXW2 | |
| GDHYDTMTRVQAKGM | 381 | Q16880 | |
| EYHVVIQAKDMGGHM | 231 | P55287 | |
| GTKMKHYFNMIEGQG | 501 | Q9NSI6 | |
| VRDMYATHLASGMLG | 431 | Q9Y2E5 | |
| TKRHLCMVMEYVEGG | 581 | Q6P0Q8 | |
| SGATARMLAKQYGHM | 201 | Q6ZW76 | |
| TGKGYEARNLHMMLS | 2181 | A6NE01 | |
| MALRYPMAVGLNKGH | 1 | Q9Y3U8 | |
| QMNGYAVTRGLKDME | 2931 | P21817 | |
| MMKTAQGGGHRTLLY | 101 | Q92736 | |
| YNGGMKELMEHLKAQ | 36 | Q52MB2 | |
| MYGVDMHVVRGRDGC | 271 | Q9H329 | |
| MSMEHRYKLNGGNLV | 71 | Q9P232 | |
| MMRTAKGDLHYFING | 836 | Q96JN8 | |
| AAKKHQNMYRLAMTG | 636 | Q92523 | |
| MVNMPRGIYHSALKG | 786 | Q5VW36 | |
| DIHFHVKMMYLGVGI | 191 | Q9P1Q5 | |
| VMSMVGYILGLGDRH | 2326 | P42345 | |
| FMNAYTMRGAGAVIH | 101 | Q96GX9 | |
| FGTMGHVIRGTVVMK | 416 | Q13423 | |
| VMIVGIDCYHDMTAG | 626 | Q96J94 | |
| IMDHMVKSDGGAYQC | 371 | O60469 | |
| GMMRHLYVVVDGSRT | 56 | Q6P1K8 | |
| SSAHIMGEAMERVYG | 156 | P26639 | |
| GSAVHKMIVDRQYMG | 176 | Q969X6 | |
| VIGLIMYGFVKAMIH | 176 | Q8IVB4 | |
| AMFNLGYMHEKGLGI | 666 | Q9UBV2 | |
| RKGAIILHVIGMIYM | 131 | Q9UI40 | |
| GKYGMFRQGMHDLKV | 131 | Q8NEB9 | |
| GVFLYHAIKSGMDMG | 596 | Q99707 | |
| MLNKAEVGHGYMDRP | 281 | Q13635 | |
| VNRKTEIISGMNHMY | 616 | Q562F6 | |
| LRVMYANGMGISFHS | 1776 | Q9NT68 | |
| AIYKLTGAVMHYGNM | 351 | Q9Y623 | |
| YPGMAHRMQKEIAAL | 1006 | P0CG38 | |
| HGVSMSERCYLMKQV | 81 | Q9GZX6 | |
| HRTQGLMIMKTVYKG | 36 | Q13546 | |
| GYVDEVMTRLMKHLG | 256 | Q8N6T7 | |
| KSQYSGQLHEVREMM | 231 | Q9BXB5 | |
| RHQGVMVGMGQKDSY | 41 | P68032 | |
| VNHRLIGMAYGQIGM | 851 | Q13733 | |
| VGRIMGMAVFHGHYI | 486 | Q9HAU4 | |
| MNNERHKGEMAYIVV | 3681 | Q63HN8 | |
| VCQYMKGLSHVAMGQ | 386 | Q8NBP0 | |
| GNMEVNVYGAIMHEV | 2036 | P04275 | |
| HVAEVMGKHYGMVPI | 296 | Q9ULX5 | |
| GMMRHLYVVVDGSRT | 56 | Q13888 | |
| TRMAMYKKSLHINGG | 816 | O94804 | |
| EYGQAMTVRVCKMDG | 36 | Q9BV90 | |
| MMHFGGYIQKQAQTE | 191 | P45379 | |
| TGMNYMKVRTGVRHA | 1171 | Q8WVM7 | |
| GKYIIEMSHMVKDNG | 111 | Q96NS1 | |
| NAMGYVRMIRSGGLH | 921 | Q2M389 | |
| MAEKVGSYMEQHGVK | 376 | Q86VQ6 | |
| DQAKHMGVMAGDIYS | 341 | Q99541 | |
| LAHVYQSQGMMRAAE | 1406 | Q6PGP7 | |
| VRSKDQHAMGMETYK | 1036 | Q70CQ2 | |
| GFAGRYVLQAMKHME | 16 | Q96DA6 | |
| REEVHKYVQMMGGRV | 121 | Q92547 | |
| LTVKHGGQYMGQLKM | 221 | Q92547 | |
| DRLQVYGGHKDMIMC | 1771 | Q9H2Y7 | |
| YGVSKVHAELMGETM | 191 | Q8IZJ6 | |
| RMHHGATVMGNKLYV | 511 | Q2WGJ6 | |
| RYSGMMETVHIRKSG | 676 | Q6PIF6 | |
| EMHAYMGKFNQRGVD | 701 | Q13224 |